Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antitumor and immune-modulatory efficacy of dual-treatment based on levamisole and/or taurine in Ehrlich ascites carcinoma-bearing mice.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Oct 2018

Ibrahim Hany M, Abdel Ghaffar Faten R, El-Elaimy Ibrahim A, Gouida Mona S, Abd El Latif Heba M

Abstract excerpt

Many alternative and complementary therapies for cancer have been reported. The objective of the present work is to examine antitumor and immune-modulatory properties of dual-treatment based on levamisole (Lms) and/or taurine (Tau) in Ehrlich ascites carcinoma-bearing mice. In the current study, Lms (10 mg/kg; subcutaneously) and Tau (640 mg/kg; intragastrically) was administered alone or as a dual-treatment. Lms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cyclophosphamide

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphocytes

Share to Myeloid-Derived Suppressor Cells

Share to Spleen

Share to Taurine

Share to Tumor Burden

Share to Tumor Escape

Source

Identifiers

PMID: 29945116
DOI: 10.1016/j.biopha.2018.06.113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antitumor and immune-modulatory efficacy of dual-treatment based on levamisole and/or taurine in Ehrlich ascites carcinoma-bearing mice.PMID 29945116Read ↗

Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing miceSemantic proximity Read ↗

Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuitSemantic proximity Read ↗

The clinical synergistic antitumor efficacy of Lienal Polypeptide combined with EGFR-TKIs for advanced NSCLCSemantic proximity Read ↗

The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma CellsSemantic proximity Read ↗

Anticancer activity of chicken cathelicidin peptides against different types of cancerSemantic proximity Read ↗

Apoptotic and anti-proliferative activity of novel platinum complex [Pt((E)-N-((E)-4-hydroxy-3-methoxybenzylidene)-2- (pyridine-2-ylmethylene)hydrazine-1-carbothioamide)] against Ehrlich Ascites carcinoma (EAC) cells in vivoSemantic proximity Read ↗

Enhanced Antitumor Effects of Thymoquinone in Combination with Paclitaxel on Hepatocellular Carcinoma Cell Lines: Role of P53 ModulationSemantic proximity Read ↗

Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation.Semantic proximity Read ↗

Antitumor Activity of Bruceantin: An Old Drug with New Promise<sup>,</sup>Semantic proximity Read ↗

Apoptosis induction in human hepatoma cell line HepG2 cells by trans- Anethole via activation of mitochondria-mediated apoptotic pathwaysSemantic proximity Read ↗

Synergistic Antileukemic Effects of Hydroxyurea and SRJ23 in T-cell Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.